- Opportunities
- Department of Defense
- Defense Health Agency (DHA)
- HT9427-26-R-E020
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Open, 4 days left
- Deadline
- Nov 20, 12:00 PM ET
- Notice type
- Solicitation
- Set-aside
- Not stated
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715, Engineering and research
- Place of performance
- Frederick, MD
- Buying office
- Defense Health AgencyOffice HT9427, Defense Health Agency (DHA)
- Solicitation number
- HT9427-26-R-E020
- Product or service code
- AN13
- Posted
- Nov 13, 2026
- Source
- SAM.govVersion 1, last change seen Nov 16, 2026, 4:30 AM UTC
Notice text
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026 Amendment 0004 – Incorporates Attachment J - Offeror questions & Government responses, Updates RPP, Attachment A – SOO, Attachment E- Draft Agreement Terms & Conditions, Attachment H – SOW Template, and adds Attachment K – CMMC Level I Self-Assessment Instructions. Amendment 0005 - Incorporates updates to RPP.
As published on SAM.gov. Attachments are listed there; FedLook does not read them yet.
Contacts
- Bryan Heickman, bryan.g.heickman.civ@health.mil
As listed in the notice. Ask questions in writing and before the questions deadline, if the notice sets one.
History
- Nov 16, 2026: first seen in the SAM.gov extract
SAM.gov shows only the latest version of a notice. FedLook keeps a copy of each day's notices and records what changed.
Other open notices in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)
Get new notices from Defense Health Agency (DHA) by email
Each morning we send the new solicitations and sources-sought notices from Defense Health Agency (DHA), with deadlines and set-asides up front. Free. Unsubscribe in one click.